CD274 and neoplasm: O-GlcNAc suppresses the degradation of PD-L1 in cancer cells, which is responsible for immune evasion in cancer [39]; high expression of PD-L1 in tumor cells has been correlated with poor prognosis in cancer patients, such as non-small cell lung cancer (NSCLC) [40].